Ignite Creation Date:
2024-05-06 @ 5:45 PM
Last Modification Date:
2024-10-26 @ 2:34 PM
Study NCT ID:
NCT05411133
Status:
RECRUITING
Last Update Posted:
2024-01-23
First Post:
2022-05-25
Brief Title:
Treatment of Cabotamig ARB202 in Advanced Gastrointestinal Cancer Patients
Sponsor:
Arbele Pty Ltd
Organization:
Arbele Limited
Organization Data
Organization:
Arbele Limited
Class:
INDUSTRY
Study ID:
A001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Arbele Pty Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None